The personalized treatment of invasive candidiasis still has a long way to go. [PDF]
Wang L +6 more
europepmc +1 more source
Studying Candida Biofilms Across Species: Experimental Models, Structural Diversity, and Clinical Implications. [PDF]
Squitieri D +6 more
europepmc +1 more source
Candidozyma auris in The Netherlands: No Evidence of Nosocomial Transmission Supported by Effective Infection Control Policies. [PDF]
de Groot CC +7 more
europepmc +1 more source
A plain language summary of the STRIVE and ReSTORE studies, which tested if rezafungin is effective and as safe as caspofungin at treating people with candidaemia and invasive candidiasis. [PDF]
Thompson GR +4 more
europepmc +1 more source
Comprehensive strategies to defeat Candida auris - challenge and insight: A review. [PDF]
Zhang J +6 more
europepmc +1 more source
Microbe Profile: <i>Candidozyma auris:</i> an emergent and resilient yeast and new antifungal strategies. [PDF]
Ramage G, Sherry L, Kean R.
europepmc +1 more source
Length of hospital and intensive care unit stay in patients with invasive candidiasis and/or candidemia treated with rezafungin: a pooled analysis of two randomised controlled trials. [PDF]
Honoré PM +13 more
europepmc +1 more source
First report of <i>Candida</i> (<i>Candidozyma) auris</i> infections in a human and a dolphin from the Dominican Republic: A One health perspective. [PDF]
Ferrara GA +5 more
europepmc +1 more source

